Invenomic Capital Management’s Lear LEA Stock Holding History

Invenomic Capital Management’s Portfolio LEA Stock Details LEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-40,400	Closed	-$3.83M	–	185
2024 Q4	$3.83M	Buy	+40,400	New	+$4.02M	0.18%	122
2022 Q3	–	Sell	-53,725	Closed	-$6.76M	–	170
2022 Q2	$6.76M	Buy	53,725 +23,252	+76%	+$3.07M	0.48%	64
2022 Q1	$3.6M	Buy	+30,473	New	+$4.95M	0.38%	73
2021 Q4	–	Sell	-8,069	Closed	-$1.26M	–	155
2021 Q3	$1.26M	Buy	+8,069	New	+$1.32M	0.41%	74
2021 Q1	–	Sell	-9,270	Closed	-$1.48M	–	140
2020 Q4	$1.48M	Sell	9,270 -3,435	-27%	-$483K	0.38%	58
2020 Q3	$1.39M	Buy	+12,705	New	+$1.45M	0.76%	47
2020 Q2	–	Sell	-1,345	Closed	-$109K	–	175
2020 Q1	$109K	Sell	1,345 -17,051	-93%	-$1.96M	0.09%	139
2019 Q4	$2.52M	Buy	+18,396	New	+$2.28M	1.01%	46

Other funds holding LEA

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Greenhaven Associates Purchase, New York $8.66B AUM 17.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LAM

Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

Invenomic Capital Management's LEA Position: Q1 2025 in Review

Invenomic Capital Management sold out of Lear (LEA) in Q1 2025, closing a stake of 40,400 shares — an estimated $3.83M sold.

Invenomic Capital Management first reported a position in LEA in Q4 2019 and held it in 8 quarters. The position peaked at $6.76M in Q2 2022. 402 funds tracked by Wall St. Rank hold LEA as of Q1 2025.

Invenomic Capital Management reported no remaining Lear position as of Q1 2025 after selling out during the quarter.
Invenomic Capital Management sold 40,400 Lear shares in Q1 2025, an estimated $3.83M.
Invenomic Capital Management first reported a position in Lear in Q4 2019 and held it in 8 quarters.
Invenomic Capital Management's Lear position peaked at $6.76M in Q2 2022.
402 funds tracked by Wall St. Rank held Lear as of Q1 2025.

Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.